Preparation of Exosomes for siRNA Delivery to Cancer Cells
December 5th, 2018
28.7K views
An exosome is a new generation of drug delivery carriers. We established an exosome isolation protocol with high yield and purity for siRNA delivery. We also encapsulated fluorescently labelled non-specific siRNA into exosomes and investigated the cellular uptake of siRNA-loaded exosomes in cancer cells.
Overview
This study presents a high-yield protocol for isolating exosomes from HEK-293 cells for siRNA delivery. The encapsulation of fluorescently labeled siRNA into exosomes was investigated, demonstrating effective cellular uptake in cancer cells.
Key Study Components
Area of Science
- Neuroscience
- Drug Delivery Systems
- RNA Interference
Background
- Exosomes are emerging as novel drug delivery vehicles.
- Efficient isolation methods are crucial for their application in therapeutics.
- siRNA delivery via exosomes has potential for cancer treatment.
- Current methods often involve complex gradients and high sucrose concentrations.
Purpose of Study
- To establish a simplified protocol for exosome isolation.
- To evaluate the encapsulation and delivery efficiency of siRNA in exosomes.
- To explore the potential of exosome-based therapies for pancreatic cancer.
Methods Used
- Harvesting exosomes from HEK-293 cells cultured in bioreactor flasks.
- Isolation using sucrose cushion ultracentrifugation.
- Electroporation for siRNA encapsulation into exosomes.
- Size exclusion chromatography for purification of exosome-siRNA complexes.
Main Results
- High yield and purity of exosomes were achieved.
- Exosomes were characterized by size and exosomal markers.
- Effective cellular uptake of siRNA-loaded exosomes was demonstrated.
- The protocol shows promise for RNA interference-based therapies.
Conclusions
- The established protocol simplifies exosome isolation and enhances siRNA delivery.
- Exosomes can serve as effective carriers for RNA-based therapies.
- This method may advance therapeutic strategies for pancreatic cancer.
Frequently Asked Questions
What are exosomes?
Exosomes are small extracellular vesicles that facilitate intercellular communication and can be used for drug delivery.
How are exosomes isolated?
Exosomes are isolated using a sucrose cushion ultracentrifugation method, which provides high yield and purity.
What is the significance of siRNA delivery?
siRNA delivery is crucial for RNA interference therapies, which can silence specific genes involved in diseases like cancer.
What cell line was used in this study?
HEK-293 cells were used for the isolation and study of exosomes.
What markers are used to characterize exosomes?
Exosomes are characterized by specific markers such as CD81, CD9, and CD63.
What potential applications do exosomes have?
Exosomes have potential applications in drug delivery, particularly for RNA-based therapies in cancer treatment.
Executive Industry Relevance
This protocol enables scalable, high-yield isolation of HEK-293 exosomes for siRNA delivery, addressing a key bottleneck in RNA interference-based therapeutic development. By simplifying exosome purification via sucrose cushion ultracentrifugation in deuterium oxide, the method reduces reagent burden and improves reproducibility for preclinical oncology programs. The demonstrated siRNA encapsulation and functional delivery into PANC-1 pancreatic cancer cells supports target validation and mechanistic de-risking in early discovery pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables functional validation of siRNA targets by delivering nucleic acids into cancer cells via a biologically relevant vesicle system.
- Operational Value: Provides a standardized isolation workflow that reduces variability in exosome yield and purity across batches.
Screening & Assay Development
- Scientific Value: Produces exosomes with consistent size (~107 nm) and marker expression (CD81, CD9, CD63) suitable for assay standardization in siRNA screening campaigns.
- Operational Value: The size exclusion chromatography step allows removal of free siRNA, enabling accurate quantification of encapsulated payload for dose-response assessments.
Translational & Preclinical Research
- Scientific Value: Demonstrates intracellular delivery of siRNA in PANC-1 cells, supporting preclinical evaluation of exosome-mediated gene silencing in pancreatic cancer models.
- Operational Value: The protocol’s weekly conditioned medium harvest from bioreactor cultures supports scalable production for lead optimization studies.
Pipeline & Workflow Integration
This method fits within the early discovery to lead identification continuum, where reliable siRNA delivery tools are essential for target interrogation and pathway validation.
- Discovery Biology: Supports hypothesis testing by enabling siRNA-mediated knockdown of candidate genes in cancer cells via exosome delivery.
- Screening: Delivers quantifiable, encapsulated siRNA to cells, facilitating reproducible readouts in high-content screening formats.
- Analytics: Nanoparticle tracking analysis and flow cytometry provide measurable outputs for exosome yield, size, and cellular uptake efficiency.
- Translational Research: Connects exosome production to functional siRNA delivery, supporting advancement decisions in RNAi-based therapeutic programs.
- Enterprise Reuse: The bioreactor-based conditioned medium generation allows for repeated exosome isolation, positioning the method as a reusable platform rather than a single-use technique.
Operational & Enterprise Impact
- Scientific Value: Enhances predictive confidence in target validation by reducing off-target effects associated with transfection reagents.
- Operational Value: The sucrose cushion method simplifies ultracentrifugation, lowering technical complexity and reagent costs compared to discontinuous gradients.
- Strategic Value: Enables risk-adjusted prioritization of siRNA targets by confirming delivery efficiency before investing in lead optimization.
- Portfolio Impact: Supports go/no-go decisions in RNAi therapeutic development by providing early evidence of intracellular delivery in relevant cancer models.
Implementation Considerations
- Requires expertise in cell culture, ultracentrifugation, and electroporation for successful exosome isolation and siRNA loading.
- Dependent on access to ultracentrifugation equipment with swing-out and fixed-angle rotors for sucrose cushion separation and washing steps.
- Necessitates standardized protocols for exosome-depleted medium and conditioned medium handling to maintain consistency across production cycles.
- Requires validation of exosome purity and siRNA encapsulation efficiency (10–20%) using nanoparticle tracking analysis, protein quantification, and flow cytometry.
- Practical limitation: The encapsulation efficiency range necessitates dose adjustment calculations to account for variable siRNA loading across batches.
Biopharma FAQs
Why does yield and purity matter for siRNA delivery vectors?
High yield and low protein contamination ensure sufficient exosome supply and reduce off-target effects, which is critical for reproducible siRNA delivery in target validation studies.
How does sucrose cushion ultracentrifugation improve exosome isolation?
Using a single sucrose cushion in deuterium oxide simplifies preparation, reduces sucrose usage, and achieves high-purity exosome pellets without the need for discontinuous gradients.
What enables effective siRNA loading into exosomes?
Electroporation facilitates siRNA encapsulation into exosomes, and subsequent size exclusion chromatography removes unencapsulated siRNA to isolate functional delivery vehicles.
Why is cellular uptake measurement important for exosome-siRNA complexes?
Flow cytometry quantification of fluorescent siRNA signal in PANC-1 cells confirms internalization and delivery efficiency, supporting go/no-go decisions in RNAi therapeutic development.
What analytical capabilities are required to assess exosome-siRNA functionality?
Nanoparticle tracking analysis, protein quantification, electron microscopy, and flow cytometry are needed to characterize exosome yield, size, purity, and cellular uptake in cancer cells.
Chapters in this video
0:04
Title
0:51
Bioreactor Flask Cell Culture
1:52
Conditioned Medium (CM) Harvesting from the Bioreactor Flask
2:41
Exosome Isolation onto a Sucrose Cushion
5:02
siRNA Encapsulation into Exosomes by Electroporation
6:11
Removal of Free siRNA Using Size Exclusion Chromatography (SEC)
7:17
Results: Effective Intracellular Delivery of siRNA Using siRNA-encapsulated Exosomes
9:11
Conclusion
